₹
1.17
Dec 24
Business Description
Biogen Pharmachem Industries Ltd
ISIN : INE703D01023
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 1 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 521.27 | |||||
Beneish M-Score | -1.19 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | -21.1 | |||||
3-Year Book Growth Rate | 1.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.13 | |||||
9-Day RSI | 28.06 | |||||
14-Day RSI | 34.73 | |||||
6-1 Month Momentum % | 8.85 | |||||
12-1 Month Momentum % | -19.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 20.88 | |||||
Quick Ratio | 20.88 | |||||
Cash Ratio | 3.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 96.09 | |||||
Operating Margin % | 68.18 | |||||
Net Margin % | -23.23 | |||||
FCF Margin % | 129.74 | |||||
ROE % | -0.63 | |||||
ROA % | -0.61 | |||||
ROIC % | 1.78 | |||||
ROC (Joel Greenblatt) % | -47.81 | |||||
ROCE % | -0.61 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 65 | |||||
PB Ratio | 1.38 | |||||
Price-to-Tangible-Book | 1.38 | |||||
Price-to-Free-Cash-Flow | 39 | |||||
Price-to-Operating-Cash-Flow | 39 | |||||
EV-to-EBIT | -216 | |||||
EV-to-EBITDA | -216 | |||||
EV-to-Revenue | 50.18 | |||||
EV-to-FCF | 40 | |||||
Price-to-Projected-FCF | 2.05 | |||||
Price-to-Net-Current-Asset-Value | 39 | |||||
Earnings Yield (Greenblatt) % | -0.47 | |||||
FCF Yield % | 2.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biogen Pharmachem Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 15.153 | ||
EPS (TTM) (₹) | -0.011 | ||
Beta | 1.7 | ||
Volatility % | 82.65 | ||
14-Day RSI | 34.73 | ||
14-Day ATR (₹) | 0.046526 | ||
20-Day SMA (₹) | 1.241 | ||
12-1 Month Momentum % | -19.61 | ||
52-Week Range (₹) | 0.98 - 1.79 | ||
Shares Outstanding (Mil) | 652.6 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biogen Pharmachem Industries Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biogen Pharmachem Industries Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Biogen Pharmachem Industries Ltd Frequently Asked Questions
What is Biogen Pharmachem Industries Ltd(BOM:531752)'s stock price today?
When is next earnings date of Biogen Pharmachem Industries Ltd(BOM:531752)?
Does Biogen Pharmachem Industries Ltd(BOM:531752) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |